The combination of adoxorubicin and cyclophosphamide (AC) followed by a taxane (Docetaxel or Paclitaxel) and epirubicin and cyclophosphamide (EC) followed by a taxane (Docetaxel or Paclitaxel) is a standard regimen for breast cancer patients.
The combination of adoxorubicin and cyclophosphamide (AC) followed by a taxane (Docetaxel or Paclitaxel) and epirubicin and cyclophosphamide (EC) followed by a taxane (Docetaxel or Paclitaxel) is a standard regimen for breast cancer patients.